Sjogren's syndrome and the need for cooperation of medical specialties for its treatment

被引:0
|
作者
Liosatos, Alexios [1 ]
机构
[1] Aristotle Univ Thessaloniki, Lab Oral & Maxillofacial Surg, Hosp Dent, Thessaloniki, Greece
关键词
Sjogren syndrome; medical specialties; cooperation; CLASSIFICATION CRITERIA; CUTANEOUS MANIFESTATIONS; CLINICAL-MANIFESTATIONS; RHEUMATOID-ARTHRITIS; SALIVARY-GLANDS; PREVALENCE; DIAGNOSIS; EXPRESSION; MANAGEMENT; DISEASES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sjogren's syndrome (SS) is an autoimmune disease that is classified as a rheumatic disease and causes inflammation of the exocrine glands, mainly affecting the salivary and lacrimal glands, leading to significant loss of function. It is the second most common systemic autoimmune disease after rheumatoid arthritis and is mainly characterized by a triad of clinical features, namely dry keratoconjunctivitis, dry mouth, and a connective tissue disease (usually Rheumatoid Arthritis). It can also affect many other tissues and organs, especially the glandular tissues and the musculoskeletal system. The cause of SS is multifactorial. The etiology is considered to be related to a combination of genetic, environmental, viral infections and modifications of the immune system. The disease destroys through the immune system the glandular epithelium of the exocrine glands, especially the salivary and lacrimal glands. The clinical picture includes intraoral manifestations (dry mouth, angular cheilitis, secondary infections, significantly increased rate of caries and erosive lesions on the teeth, etc.), ocular manifestations (dry eye, burning sensation in the eyes, etc.). manifestations from the musculoskeletal, gastrointestinal, nervous system etc. Dry skin and rash may also coexist. Treatment of the disease is symptomatic. Patients should take various general measures, such as very meticulous oral hygiene, frequent use of artificial tears and saliva substitutes, lip lubricants, etc. Systemic manifestations and pain (eg arthralgias) are treated with drugs used to treat other autoimmune diseases, such as NSAIDs, corticosteroids, immunosuppressants, etc. The difficulty of diagnosis, the unknown etiology, the complexity of the manifestations of the syndrome, the need for early treatment indicate the need for cooperation of many specialties for both diagnosis and treatment of the syndrome. The dentist, as well as the physician, the otolaryngologist or the ophthalmologist will probably be the first doctors who will be called to diagnose the syndrome, to note the symptoms and to refer patients to more competent doctors or to the appropriate examinations. This requires a good knowledge of the pathophysiology of the syndrome, the methods of diagnosis and the therapeutic approaches, and the present review aims to contribute to this need.
引用
收藏
页码:507 / 529
页数:23
相关论文
共 50 条
  • [31] Histopathological differences between primary Sjogren's syndrome and Sjogren's syndrome accompanied by scleroderma
    Kucuk, Ulku
    Sarioglu, Sulen
    Cetin, Pinar
    Sari, Ismail
    Birlik, Merih
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (03) : 319 - 322
  • [32] Updates in diagnostics, treatments, and correlations between oral and ocular manifestations of Sjogren's syndrome
    Choudhry, Hassaam S.
    Hosseini, Shayan
    Choudhry, Hannaan S.
    Fatahzadeh, Mahnaz
    Khianey, Reena
    Dastjerdi, Mohammad H.
    OCULAR SURFACE, 2022, 26 : 75 - 87
  • [33] Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjogren's syndrome
    Nakamura, Hideki
    Shimizu, Toshimasa
    Takagi, Yukinori
    Takahashi, Yoshiko
    Horai, Yoshiro
    Nakashima, Yoshikazu
    Sato, Shuntaro
    Shiraishi, Hirokazu
    Nakamura, Tatsufumi
    Fukuoka, Junya
    Nakamura, Takashi
    Kawakami, Atsushi
    BMC MUSCULOSKELETAL DISORDERS, 2015, 16
  • [34] A Pilot Study of a Panel of Ocular Inflammation Biomarkers in Patients with Primary Sjogren's Syndrome
    Boto de los Bueis, Ana
    de la Fuente, Miguel
    Montejano-Milner, Rafael
    del Hierro Zarzuelo, Almudena
    Vecino, Elena
    Acera, Arantxa
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (04) : 2881 - 2894
  • [35] Hypocomplementemia in Primary Sjogren's Syndrome: A Retrospective Study of 120 Treatment-Naive Chinese Patients
    Zhou, Meiju
    Yuan, Fang
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 359 - 366
  • [36] Sjogren's Syndrome: Early diagnosis and effective treatment
    Witte, Torsten
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (24) : 1778 - 1782
  • [37] Pathogenesis and treatment of Sjogren's syndrome: Review and update
    Zhan, Qipeng
    Zhang, Jianan
    Lin, Yubin
    Chen, Wenjing
    Fan, Xinzou
    Zhang, Dunfang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] Seronegative primary Sjogren's syndrome, a distinct subtype of primary Sjogren's syndrome in Chinese patients
    Lan, Jingying
    Deng, Chaoqiong
    Huang, Heqing
    Rao, Peishi
    Chen, Yangchun
    Shi, Yingying
    Chen, Jie
    Shi, Guixiu
    Liu, Yuan
    Chen, Shiju
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [39] Novel autoantibodies in Sjogren's syndrome
    Shen, Long
    Suresh, Lakshmanan
    Lindemann, Matthew
    Xuan, Jingxiu
    Kowal, Przemek
    Malyavantham, Kishore
    Ambrus, Julian L., Jr.
    CLINICAL IMMUNOLOGY, 2012, 145 (03) : 251 - 255
  • [40] Classification criteria of Sjogren's syndrome
    Goules, Andreas V.
    Tzioufas, Athanasios G.
    Moutsopoulos, Haralampos M.
    JOURNAL OF AUTOIMMUNITY, 2014, 48-49 : 42 - 45